Mesa Laboratories Inc
NASDAQ:MLAB
Mesa Laboratories Inc
NASDAQ:MLAB
Price:
93.27
USD
2.27%
Market Cap:
$514.9m
Balance Sheet
Balance Sheet Decomposition
Mesa Laboratories Inc
Mesa Laboratories Inc
Balance Sheet Decomposition is not available for
Mesa Laboratories Inc
Mesa Laboratories Inc
Balance Sheet
Mesa Laboratories Inc
Mesa Laboratories Inc
Currency: USD
| Mar-2002 | Mar-2003 | Mar-2004 | Mar-2005 | Mar-2006 | Mar-2007 | Mar-2008 | Mar-2009 | Mar-2010 | Mar-2011 | Mar-2012 | Mar-2013 | Mar-2014 | Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
4
|
5
|
7
|
7
|
6
|
3
|
6
|
9
|
11
|
4
|
7
|
4
|
6
|
2
|
6
|
6
|
6
|
10
|
81
|
264
|
49
|
33
|
28
|
27
|
|
| Cash Equivalents |
4
|
5
|
7
|
7
|
6
|
3
|
6
|
9
|
11
|
4
|
7
|
4
|
6
|
2
|
6
|
6
|
6
|
10
|
81
|
264
|
49
|
33
|
28
|
27
|
|
| Total Receivables |
2
|
2
|
2
|
2
|
2
|
4
|
4
|
4
|
4
|
7
|
7
|
9
|
9
|
12
|
15
|
14
|
14
|
13
|
21
|
24
|
41
|
43
|
39
|
42
|
|
| Accounts Receivables |
2
|
2
|
2
|
2
|
2
|
4
|
4
|
4
|
4
|
7
|
7
|
9
|
9
|
12
|
15
|
14
|
14
|
13
|
21
|
24
|
41
|
43
|
39
|
42
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
2
|
2
|
2
|
2
|
2
|
3
|
4
|
5
|
5
|
6
|
4
|
6
|
8
|
12
|
14
|
14
|
9
|
7
|
14
|
11
|
25
|
35
|
33
|
25
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
4
|
3
|
2
|
2
|
3
|
4
|
6
|
5
|
9
|
9
|
9
|
8
|
|
| Total Current Assets |
9
|
10
|
11
|
11
|
11
|
11
|
14
|
19
|
21
|
17
|
19
|
20
|
27
|
30
|
37
|
36
|
32
|
34
|
123
|
304
|
124
|
119
|
109
|
103
|
|
| PP&E Net |
1
|
1
|
1
|
1
|
1
|
4
|
4
|
4
|
4
|
7
|
7
|
7
|
8
|
10
|
17
|
26
|
24
|
22
|
25
|
24
|
39
|
37
|
41
|
49
|
|
| PP&E Gross |
1
|
1
|
1
|
1
|
1
|
4
|
4
|
4
|
4
|
7
|
7
|
7
|
8
|
10
|
17
|
26
|
24
|
22
|
25
|
24
|
39
|
37
|
41
|
49
|
|
| Accumulated Depreciation |
2
|
2
|
2
|
2
|
2
|
2
|
2
|
3
|
3
|
4
|
4
|
5
|
6
|
7
|
8
|
10
|
10
|
11
|
13
|
16
|
18
|
20
|
23
|
26
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
3
|
2
|
2
|
3
|
12
|
10
|
15
|
25
|
33
|
41
|
38
|
43
|
33
|
120
|
112
|
250
|
217
|
114
|
97
|
|
| Goodwill |
4
|
4
|
4
|
4
|
4
|
5
|
5
|
5
|
6
|
15
|
15
|
24
|
38
|
45
|
66
|
72
|
66
|
66
|
142
|
161
|
291
|
286
|
180
|
182
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
3
|
3
|
2
|
3
|
|
| Other Assets |
4
|
4
|
4
|
4
|
4
|
5
|
5
|
5
|
6
|
15
|
15
|
24
|
38
|
45
|
66
|
72
|
66
|
66
|
142
|
161
|
291
|
286
|
180
|
182
|
|
| Total Assets |
14
N/A
|
15
+6%
|
16
+7%
|
17
+2%
|
17
-1%
|
22
+36%
|
26
+14%
|
30
+16%
|
34
+14%
|
51
+51%
|
51
+0%
|
66
+30%
|
98
+48%
|
117
+20%
|
161
+37%
|
172
+7%
|
164
-4%
|
157
-4%
|
409
+161%
|
602
+47%
|
707
+18%
|
662
-6%
|
447
-32%
|
433
-3%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
3
|
3
|
2
|
2
|
3
|
3
|
5
|
8
|
6
|
6
|
6
|
|
| Accrued Liabilities |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
3
|
3
|
3
|
6
|
5
|
8
|
7
|
8
|
11
|
16
|
18
|
26
|
23
|
21
|
40
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
0
|
0
|
0
|
3
|
3
|
1
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
101
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
4
|
10
|
6
|
6
|
7
|
7
|
10
|
14
|
14
|
17
|
17
|
|
| Total Current Liabilities |
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
10
|
4
|
5
|
10
|
15
|
24
|
17
|
17
|
24
|
26
|
33
|
48
|
43
|
44
|
164
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
4
|
17
|
23
|
42
|
54
|
45
|
21
|
140
|
146
|
218
|
183
|
222
|
77
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
3
|
3
|
2
|
5
|
5
|
5
|
4
|
3
|
1
|
22
|
16
|
39
|
34
|
20
|
20
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
1
|
4
|
0
|
0
|
0
|
1
|
1
|
8
|
8
|
16
|
12
|
|
| Total Liabilities |
1
N/A
|
1
+40%
|
1
+14%
|
1
+50%
|
2
+25%
|
2
+7%
|
2
+13%
|
2
+11%
|
2
+20%
|
14
+488%
|
7
-52%
|
13
+94%
|
33
+152%
|
44
+32%
|
76
+74%
|
74
-3%
|
65
-12%
|
46
-30%
|
189
+316%
|
195
+3%
|
314
+61%
|
268
-14%
|
301
+12%
|
274
-9%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
2
|
1
|
1
|
1
|
1
|
5
|
5
|
5
|
5
|
6
|
9
|
11
|
16
|
18
|
21
|
26
|
31
|
40
|
158
|
318
|
314
|
332
|
344
|
359
|
|
| Retained Earnings |
12
|
13
|
14
|
14
|
14
|
16
|
19
|
23
|
26
|
31
|
36
|
42
|
49
|
56
|
65
|
74
|
68
|
73
|
72
|
73
|
77
|
74
|
183
|
189
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
1
|
2
|
10
|
16
|
4
|
13
|
15
|
10
|
|
| Total Equity |
14
N/A
|
15
+4%
|
15
+6%
|
15
N/A
|
15
-3%
|
21
+39%
|
24
+14%
|
28
+16%
|
31
+13%
|
36
+17%
|
44
+21%
|
53
+20%
|
64
+22%
|
74
+14%
|
85
+15%
|
98
+15%
|
99
+2%
|
111
+12%
|
220
+98%
|
406
+85%
|
394
-3%
|
394
0%
|
145
-63%
|
160
+10%
|
|
| Total Liabilities & Equity |
14
N/A
|
15
+6%
|
16
+7%
|
17
+2%
|
17
-1%
|
22
+36%
|
26
+14%
|
30
+16%
|
34
+14%
|
51
+51%
|
51
+0%
|
66
+30%
|
98
+48%
|
117
+20%
|
161
+37%
|
172
+7%
|
164
-4%
|
157
-4%
|
409
+161%
|
602
+47%
|
707
+18%
|
662
-6%
|
447
-32%
|
433
-3%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
5
|
5
|
5
|
5
|
5
|
|
Switch to:
Switch to:
See Also
Discover More
